Rheumatology

Thomas D. Boyer Liver Institute at the University of Arizona receives special designation to support Hep C patients

Thomas D. Boyer Liver Institute Sign

The Thomas D. Boyer Liver Institute at the University of Arizona, in collaboration with the Arizona Department of Health Services, has received formal designation from the Center for Disease Control as a participant of the 340B Drug Pricing Program. This special designation benefits Southern Arizona patients living with Hepatitis C and their providers by increasing access to services and discounted prescription drugs.

Psychiatry Grand Rounds: What is a Nootropic?

We are streaming this online via Zoom, password 732633. To register your attendance, at the beginning of the presentation: please text 142009 to 866-327-3062. This code is only valid for the day of the event. If you haven't set up your account yet, please do so at cams.cme.arizona.edu, and be sure to enter your cell phone number so the system captures your attendance when you text the code. 

Potential Target to Diagnose, Monitor Cervical Cancer Treatment Aim of UArizona Health Sciences Researchers

TUCSON, Ariz. – University of Arizona Health Sciences researchers’ quest to better understand the vaginal microbiome and its role in human papillomavirus (HPV) infection, which may progress into cervical cancer, has revealed potential new targets for early detection and monitoring treatment – proteins known as immune checkpoints.

Pain and Your Brain: How Do Mind-Body Techniques Affect the Central Mechanisms of Pain?

Join us as UArizona's Dr. Ann Marie Chiasson discusses the impact of pain on the brain. She will provide an overview of pain transmission, pain circuitry, and changes in the structure and functioning of the brain. She will highlight some of the physical changes that can be seen via imaging of the brain such as MRI for those experiencing chronic pain.

Pages

Subscribe to RSS - Rheumatology